FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995540652> ?p ?o ?g. }

• W1995540652 endingPage "437" @default.
• W1995540652 startingPage "430" @default.
• W1995540652 abstract "Insulin mimetics from natural sources are potential therapeutics that can act alone or supplement insulin and other anti-diabetic drugs in the prevention and treatment of diabetes. We recently reported the insulin-like glucose transport stimulatory activity of tannic acid (TA) in 3T3-L1 adipocytes. In this study, we find that chemically synthesized 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (beta-PGG), one of the components of TA, as well as its natural anomer alpha-PGG possess activity. Mechanistic studies in adipocytes with alpha-PGG, the more potent of the two anomers, reveal that inhibitors that block the insulin-mediated glucose transport, including one that inhibits the insulin receptor (IR), also completely abolish the glucose transport activated by alpha-PGG. In addition, alpha-PGG induces phosphorylation of the IR and Akt, activates PI 3-kinase, and stimulates membrane translocation of GLUT 4. Receptor binding studies indicate that alpha-PGG binds to the IR and affects the binding between insulin and IR by reducing the maximum binding of insulin to IR without significantly altering the binding affinity of insulin to IR. Western blotting analysis of the products of a cross-linking reaction suggests that alpha-PGG may bind to IR at a site located on the alpha-subunit of the receptor. Animal studies demonstrate that PGG reduces blood glucose levels and improves glucose tolerance in diabetic and obese animals. Our results suggest that PGG may serve as a model for the development of new types of anti-diabetic and anti-metabolic syndrome therapeutics." @default.
• W1995540652 created "2016-06-24" @default.
• W1995540652 creator A5003978094 @default.
• W1995540652 creator A5006249239 @default.
• W1995540652 creator A5008610307 @default.
• W1995540652 creator A5032938103 @default.
• W1995540652 creator A5036487272 @default.
• W1995540652 creator A5044424113 @default.
• W1995540652 creator A5046786261 @default.
• W1995540652 creator A5049423787 @default.
• W1995540652 creator A5086433908 @default.
• W1995540652 date "2005-10-01" @default.
• W1995540652 modified "2023-09-27" @default.
• W1995540652 title "Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-d-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway" @default.
• W1995540652 cites W1497823936 @default.
• W1995540652 cites W1510018037 @default.
• W1995540652 cites W1539018364 @default.
• W1995540652 cites W1906763261 @default.
• W1995540652 cites W1966624724 @default.
• W1995540652 cites W1968285698 @default.
• W1995540652 cites W1969437387 @default.
• W1995540652 cites W1975109027 @default.
• W1995540652 cites W1977867939 @default.
• W1995540652 cites W1978002465 @default.
• W1995540652 cites W1985500645 @default.
• W1995540652 cites W1996596178 @default.
• W1995540652 cites W1998219095 @default.
• W1995540652 cites W1999693007 @default.
• W1995540652 cites W2014302025 @default.
• W1995540652 cites W2014887370 @default.
• W1995540652 cites W2020331673 @default.
• W1995540652 cites W2022589777 @default.
• W1995540652 cites W2028212562 @default.
• W1995540652 cites W2042258388 @default.
• W1995540652 cites W2049702067 @default.
• W1995540652 cites W2054222268 @default.
• W1995540652 cites W2062120558 @default.
• W1995540652 cites W2066637531 @default.
• W1995540652 cites W2067096633 @default.
• W1995540652 cites W2073638865 @default.
• W1995540652 cites W2105922835 @default.
• W1995540652 cites W2107701861 @default.
• W1995540652 cites W2112997504 @default.
• W1995540652 cites W2125682093 @default.
• W1995540652 cites W2134371712 @default.
• W1995540652 cites W2140042907 @default.
• W1995540652 cites W2143345681 @default.
• W1995540652 cites W2156604743 @default.
• W1995540652 cites W2156805509 @default.
• W1995540652 cites W2949468047 @default.
• W1995540652 cites W36699941 @default.
• W1995540652 cites W90761774 @default.
• W1995540652 doi "https://doi.org/10.1016/j.bbrc.2005.08.103" @default.
• W1995540652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16137651" @default.
• W1995540652 hasPublicationYear "2005" @default.
• W1995540652 type Work @default.
• W1995540652 sameAs 1995540652 @default.
• W1995540652 citedByCount "89" @default.
• W1995540652 countsByYear W19955406522012 @default.
• W1995540652 countsByYear W19955406522013 @default.
• W1995540652 countsByYear W19955406522014 @default.
• W1995540652 countsByYear W19955406522015 @default.
• W1995540652 countsByYear W19955406522016 @default.
• W1995540652 countsByYear W19955406522017 @default.
• W1995540652 countsByYear W19955406522018 @default.
• W1995540652 countsByYear W19955406522019 @default.
• W1995540652 countsByYear W19955406522020 @default.
• W1995540652 countsByYear W19955406522021 @default.
• W1995540652 countsByYear W19955406522022 @default.
• W1995540652 countsByYear W19955406522023 @default.
• W1995540652 crossrefType "journal-article" @default.
• W1995540652 hasAuthorship W1995540652A5003978094 @default.
• W1995540652 hasAuthorship W1995540652A5006249239 @default.
• W1995540652 hasAuthorship W1995540652A5008610307 @default.
• W1995540652 hasAuthorship W1995540652A5032938103 @default.
• W1995540652 hasAuthorship W1995540652A5036487272 @default.
• W1995540652 hasAuthorship W1995540652A5044424113 @default.
• W1995540652 hasAuthorship W1995540652A5046786261 @default.
• W1995540652 hasAuthorship W1995540652A5049423787 @default.
• W1995540652 hasAuthorship W1995540652A5086433908 @default.
• W1995540652 hasConcept C112446052 @default.
• W1995540652 hasConcept C126322002 @default.
• W1995540652 hasConcept C134018914 @default.
• W1995540652 hasConcept C161573976 @default.
• W1995540652 hasConcept C170493617 @default.
• W1995540652 hasConcept C185592680 @default.
• W1995540652 hasConcept C185967709 @default.
• W1995540652 hasConcept C2777391703 @default.
• W1995540652 hasConcept C2777866211 @default.
• W1995540652 hasConcept C2779306644 @default.
• W1995540652 hasConcept C55493867 @default.
• W1995540652 hasConcept C71924100 @default.
• W1995540652 hasConcept C86803240 @default.
• W1995540652 hasConceptScore W1995540652C112446052 @default.
• W1995540652 hasConceptScore W1995540652C126322002 @default.
• W1995540652 hasConceptScore W1995540652C134018914 @default.
• W1995540652 hasConceptScore W1995540652C161573976 @default.
• W1995540652 hasConceptScore W1995540652C170493617 @default.

• next